Oncogene is a leading international journal dedicated to publishing high-impact research on the molecular basis of cancer. It explores the genetic and biochemical mechanisms underlying oncogenesis, tumor development, and metastasis. Its broad scope covers topics including tumor suppressor genes, signal transduction pathways, cell cycle regulation, and the development of novel therapeutic strategies. The journal is indexed in major databases, including Scopus, CAS, and Web of Science, and maintains a high impact factor.
It focuses on various aspects, such as the identification and characterization of oncogenes, the study of gene mutations and epigenetic modifications in cancer, and the development of targeted therapies. It encompasses a range of experimental approaches, from cell culture and animal models to clinical trials, aiming to translate basic research findings into clinical applications. It covers numerous cancer types, promoting a comprehensive understanding of cancer biology. Its target audience includes cancer researchers, oncologists, and other professionals in related fields.
By contributing research findings to Oncogene, scientists ensure their work reaches a broad audience and contribute to the advancement of cancer research. Submissions on cancer genetics, cancer immunotherapy and experimental medicine are welcome.